Baseline characteristics of patients with COPD treated with Budesonide / Glycopyrronium / Formoterol in the real world; The RECORD Study

被引：0
|
作者：
Watz, Henrik [1 ]
Halbach, Marija [2 ]
Saathoff, Matthias [2 ]
Morris, Tamsin [3 ]
Watt, Michael
Singh, Dave [4 ,5 ]
机构：
[1] LungenClin Grosshansdorf, Pneumol Forschungsinst, Grosshansdorf, Germany
[2] AstraZeneca GmbH, AstraZeneca Deutschland, Hamburg, Germany
[3] AstraZeneca GmbH, Astrazeneca UK, London, England
[4] AstraZeneca GmbH, Astrazeneca UK, London, England
[5] Univ Manchester, Div Infect Immun Resp Med, Manchester, Lancs, England
来源：
INNERE MEDIZIN | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P11-02
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [41] A Prospective, Non-Interventional, Multi-Center Study To Evaluate The Effectiveness Of Glycopyrronium Bromide For The Treatment Of COPD Patients In Real-World Clinical Practice (glare: Glycopyrronium Bromide For The Maintenance Treatment Of COPD In A Real World Setting)
    Chan, P.
    Lin, C.
    Hsu, J.
    Hang, L.
    Huang, W.
    Chen, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [42] Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation
    Suraya, Ratoe
    Nagano, Tatsuya
    Ryanto, Gusty Rizky Teguh
    Effendi, Wiwin Is
    Hazama, Daisuke
    Katsurada, Naoko
    Yamamoto, Masatsugu
    Tachihara, Motoko
    Emoto, Noriaki
    Nishimura, Yoshihiro
    Kobayashi, Kazuyuki
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [43] Real-world safety of budesonide/glycopyrrolate/formoterol in Chinese patients with chronic obstructive pulmonary disease
    Sun, Yongchang
    Chen, Yunfeng
    Zhang, Xiuwei
    Guo, Ruibin
    Zhou, Luqian
    Feng, Jiaxi
    Xiong, Xiaomin
    Xu, Weiguo
    Li, Guoping
    Zhang, Jing
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [44] Real-world effectiveness of budesonide/ glycopyrrolate/formoterol in Chinese patients with chronic obstructive pulmonary disease
    Sun, Yongchang
    Chen, Yunfeng
    Zhang, Xiuwei
    Guo, Ruibin
    Zhou, Luqian
    Feng, Jiaxi
    Xiong, Xiaomin
    Xu, Weiguo
    Li, Guoping
    Zhang, Jing
    RESPIROLOGY, 2024, 29 : 156 - 156
  • [45] Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success
    Mullerova, Hana
    Chan, Jeffrey Shi Kai
    Heatley, Heath
    Carter, Victoria
    Townend, John
    Skinner, Derek
    Franzen, Stefan
    Marshall, Jonathan
    Price, David
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1153 - 1166
  • [46] Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler® Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes
    Gabriella Gálffy
    Maria Szilasi
    Lilla Tamási
    Pulmonary Therapy, 2019, 5 : 165 - 177
  • [47] Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
    Calverley, Peter M.
    Eriksson, Goran
    Jenkins, Christine R.
    Anzueto, Antonio R.
    Make, Barry J.
    Persson, Anders
    Fageras, Malin
    Postma, Dirkje S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 13 - 25
  • [48] Effects of add-on treatment with budesonide/formoterol combination in eosinophilic COPD patients
    Akamatsu, Taisuke
    Shirai, Toshihiro
    Tanaka, Yuko
    Watanabe, Hirofumi
    Endo, Yoshinari
    Shimoda, Yukiko
    Suzuki, Takahito
    Noguchi, Rie
    Saigusa, Mika
    Yamamoto, Akito
    Shishido, Yuichiro
    Akita, Takefumi
    Morita, Satoru
    Asada, Kazuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [49] Early Efficacy Of Budesonide/formoterol In Patients With Moderate, Severe, And Very Severe COPD
    Similowski, T.
    Eriksson, G.
    Postma, D.
    Jenkins, C. R.
    Anzueto, A.
    Make, B. J.
    Fageras, M.
    Persson, A.
    Calverley, P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [50] BASELINE CHARACTERISTICS, INCLUDING HOSPITALIZATIONS, OF ASTHMA PATIENTS TREATED WITH DUPILUMAB IN THE REAL WORLD: THE RAPID REGISTRY
    Lugogo, N. L.
    Soler, X.
    Peters, A. T.
    Cote, A.
    Hilberg, O.
    Wang, J.
    Xia, C.
    Zhang, Y.
    Gomez, L. D. P.
    Jacob-Nara, J. A.
    Radwan, A.
    Rowe, P. J.
    Deniz, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S46 - S47
12345